Administration of Vincristine in a Patient with Machado-Joseph Disease

Publisher： Karger

E-ISSN： 1423-0232|82|3|165-167

ISSN： 0030-2414

Source： Oncology, Vol.82, Iss.3, 2012-03, pp. : 165-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular analyses of Machado-Joseph disease

By  

Cytogenetic and Genome Research, Vol. 100, Iss. 1-4, 2003-10 ,pp. : 261-275

Karger

Access to resources Recommend Favorite

Excessive neural synchrony in Machado‐Joseph disease responsive to subthalamic nucleus stimulation

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 3, 2015-03 ,pp. : 437-438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel candidate blood‐based transcriptional biomarkers of machado‐joseph disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 968-975

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sentinel Event Alert: Preventing Vincristine Administration Errors

By  

JCAH Perspectives, Vol. 25, Iss. 9, 2005-09 ,pp. : 10-11

Joint Commission Resources

Access to resources Recommend Favorite

Elevation of the Pacing Threshold: A Side Effect in a Patient with Pacemaker Undergoing Therapy with Doxorubicin and Vincristine

By  

Oncology, Vol. 56, Iss. 2, 1999-02 ,pp. : 110-111

Karger

Access to resources Recommend Favorite